These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 8864777

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Blood sugar regulation during treatment with indapamide in hypertensive diabetics.
    Roux P, Courtois H.
    Postgrad Med J; 1981; 57 Suppl 2():70-2. PubMed ID: 7322961
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A, Catalano M.
    Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
    Ueda Y, Aoi W, Yamachika S, Shikaya T.
    Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
    [Abstract] [Full Text] [Related]

  • 48. Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
    Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen WF.
    Drugs; 1992; 44 Suppl 1():74-84. PubMed ID: 1283588
    [Abstract] [Full Text] [Related]

  • 49. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.
    Alemayehu C, Mitchell G, Aseffa A, Clavarino A, McGree J, Nikles J.
    Trials; 2017 Oct 10; 18(1):470. PubMed ID: 29017595
    [Abstract] [Full Text] [Related]

  • 50. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
    Oksa A, Gajdos M, Fedelesová V, Spustová V, Dzúrik R.
    J Cardiovasc Pharmacol; 1994 Jan 10; 23(1):79-86. PubMed ID: 7511740
    [Abstract] [Full Text] [Related]

  • 51. [ACE-inhibitors and glucose metabolism].
    Dietze GJ, Rett K, Wicklmayr M, Mehnert H.
    Wien Med Wochenschr; 1990 Jan 31; 140(1-2):35-9. PubMed ID: 2408249
    [Abstract] [Full Text] [Related]

  • 52. Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril.
    Golik A, Weissgarten J, Evans S, Cohen N, Zaidenstein R, Modai D, Cotariu D.
    Clin Chim Acta; 1995 Aug 31; 240(1):89-94. PubMed ID: 8582063
    [No Abstract] [Full Text] [Related]

  • 53. [A protein-restricted diet combined with ACE inhibitors does not improve insulin sensitivity in renal hypertension].
    Spustová V, Stefiková K, Oksa A, Dzúrik R.
    Vnitr Lek; 1996 Mar 31; 42(3):157-61. PubMed ID: 8686202
    [Abstract] [Full Text] [Related]

  • 54. Enalapril improves glucose tolerance in two rat models: a new hypertensive diabetic strain and a fructose-induced hyperinsulinaemic rat.
    Rosenthal T, Erlich Y, Rosenmann E, Grossman E, Cohen A.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 31; 22(1):S353-4. PubMed ID: 9072425
    [Abstract] [Full Text] [Related]

  • 55. Enalapril: a well-tolerated and efficacious agent for the paediatric hypertensive patient.
    Miller K, Atkin B, Rodel PV, Walker JF.
    J Hypertens Suppl; 1986 Dec 31; 4(5):S413-6. PubMed ID: 3033181
    [Abstract] [Full Text] [Related]

  • 56. Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.
    Passa P, Tugaye A, Gauville C, Canivet J.
    Diabete Metab; 1981 Sep 31; 7(3):155-9. PubMed ID: 7033007
    [Abstract] [Full Text] [Related]

  • 57. Bronchial responses to enalapril in asthmatic, hypertensive patients.
    Mue S, Tamura G, Yamauchi K, Fujimoto Y, Inoue H, Takishima T.
    Clin Ther; 1990 Sep 31; 12(4):335-43. PubMed ID: 1699664
    [Abstract] [Full Text] [Related]

  • 58. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A, Hueso M, Sanz V, Rejas J, Sarrias J, Alsina J, Grinyó JM.
    Transplant Proc; 2002 Feb 31; 34(1):403-6. PubMed ID: 11959345
    [No Abstract] [Full Text] [Related]

  • 59. [PRIVILEGIYA (Privilege) study - Prestarium in the treatment of arterial hypertension: antihypertensive effectiveness and safety in comparison with enalapril].
    Karpov IuA, Deev AD, PRIVILEGIYA Study.
    Kardiologiia; 2007 Feb 31; 47(7):35-40. PubMed ID: 18260893
    [No Abstract] [Full Text] [Related]

  • 60. Antihypertensive drugs and diabetes mellitus.
    Parving HH.
    Dan Med Bull; 1987 Dec 31; 34 Suppl 1():16-7. PubMed ID: 3436168
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.